全世界有十一分之一的人患有糖尿病,而二分之一的糖尿病人不知道自己患有糖尿病。其中大多数(约90%)患有2型糖尿病。

糖尿病是失明,截肢,心脏病,肾衰竭和早期死亡的主要原因。简单的操作(例如定期进行葡萄糖监测)可以降低风险。

为了创造明天的药物,iQ Group Global致力于与其他人合作,提高对糖尿病的认识并支持糖尿病患者。Diabetes NSW & ACTDiabetes Queensland.

在世界糖尿病日这一天,我们向人们展示了定期监测血糖对预防糖尿病引起的并发症的重要性。

患有糖尿病会怎样

Addressing the Challenges of Invasive Glucose Monitoring

Download our whitepaper to learn more on:

  • The global diabetes epidemic
  • The challenges of currently available glucose monitoring technologies
  • The urgent need for a non-invasive glucose monitoring option
  • How improved testing will help millions of people living with diabetes

A NON-INVASIVE FUTURE: THE SALIVA GLUCOSE BIOSENSOR

Currently, the only approved methods to monitor glucose levels in people with diabetes are painful, invasive and inconvenient. At The iQ Group Global, we are committed to creating a pain-free, non-invasive future for glucose monitoring for people living with diabetes.

With our Saliva Glucose Biosensor, we intend to replace painful and invasive finger pricking for people living with diabetes – so that people with diabetes can thrive, not just survive. 

与合作伙伴关系

想更多地了解唾液葡萄糖生物传感器?

Resources:
About World Diabetes Day 2019: 
https://worlddiabetesday.org/
Know your Type 2 diabetes risk – take the IDF risk assessment: 
https://www.idf.org/type-2-diabetes-risk-assessment/
About 
Diabetes NSW & ACT and Diabetes Queensland.